Pre-made Satumomab benchmark antibody (Radiolabelled antibody, anti-TAG-72 therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-987

Pre-made Satumomab benchmark antibody (Radiolabelled antibody, anti-TAG-72 therapeutic antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Indium (111In) satumomab pendetide (trade name OncoScint CR13) is a mouse monoclonal antibody which is used for cancer diagnosis.[1] The antibody, satumomab, is linked to pendetide, a derivative of DTPA. Pendetide acts as a chelating agent for the radionuclide indium-111.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-987-1mg 1mg 3090
GMP-Bios-INN-987-10mg 10mg Inquiry
GMP-Bios-INN-987-100mg 100mg Inquiry
GMP-Bios-INN-987-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Satumomab Biosimilar, Radiolabelled Antibody: Anti-Tag-72 therapeutic antibody
INN Name Satumomab
TargetTAG-72
FormatRadiolabelled antibody
DerivationMus musculus
Species Reactivityhuman
CH1 IsotypeIgG1 - kappa
VD LCIgG1 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesCytogen Corp. (Princeton NJ USA) / Lonza Biologics (Basel Switzerland)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0